Clinical Trials Browser

Phase 2/3 × Fibroblast Growth Factor 7 × Gastrointestinal × Clear all

NCT00393822 2014-07-15

A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Stage 2B or 3 Locally Advanced, Colon Cancer

Phase 2/3 Completed

Gastrointestinal

Colonic Neoplasms, Neoplasms, Stomatitis